Activation of stress-activated protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin

Cancer Research

Volumn 56, Issue 3, 1996, Pages 637-644

  Kuroki, David W ^a   Bignami, Gary S ^b   Wattenberg, Elizabeth V ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HAWAII BIOTECH INC   (United States)

^c Box 807 Mayo   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCIUM; EGTAZIC ACID; EPIDERMAL GROWTH FACTOR; GRAMICIDIN; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PALYTOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE; THAPSIGARGIN; ACRYLAMIDE DERIVATIVE; CARCINOGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 9; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SODIUM; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INDUCTION; ION TRANSPORT; MOUSE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN TUMOR; SODIUM TRANSPORT; STRESS; TUMOR PROMOTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

3T3 CELLS; ACRYLAMIDES; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOGENS; ENZYME ACTIVATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SODIUM; TETRADECANOYLPHORBOL ACETATE;

EID: 0029664514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Moore, R. E , and Bartolini, G. Structure of palytoxin. J Am. Chem. Soc., 103: 2491-2494, 1981.
2. Fujiki, H , Suganuma, M., Tahira, T., Yoshioka, A , Nakayasu, M., Endo, Y , Shudo, K., Takayama, S., Moore, R. E., and Sugimura, T. Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin and palytoxin. In: H. Fujiki, E. Hecker, R. E. Moore, T. Sugimura, and I. B., Weinstein (eds.). Cellular Interactions by Environmental Tumor Promoters, pp. 37-45. Japan Sci. Soc. Press Utrecht Tokyo/VNU Science Press, 1984.
3. Fujiki, H., Suganuma, M., Nakayasu, M., Hakii, H., Horiuchi, T., Takayama, S., and Sugimura, T. Palytoxin is a non-12-O-terradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcino genes is Carcinogenesis (Lond.), 7: 707-710, 1986.
4. Levine, L., and Fujiki, H. Stimulation of arachidonic acid metabolism by different types of tumor promoters. Carcinogenesis (Lond). 6: 1631-1634, 1985.
5. Wattenberg, E V., Fujiki, H., and Rosner, M. R. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter. Cancer Res., 47: 4618-4622, 1987
6. +-ATPase. Toxicon, 27. 1171-1187, 1989.
7. Wattenberg, E. V., Byron, K L., Villereal, M. L., Fujiki, H , and Rosner, M R. Sodium as a mediator of non-phorbol tumor promoter action. J. Biol. Chem., 264-14668-14673, 1989.
8. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (Lond.), 308. 693-698, 1984.
9. Suganuma, M , Fujiki, H., Okabe, S., Nishiwaki, S , Brautigan, D., Ingebritsen, T. S., and Rosner, M. R. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon, 30: 873-878, 1992.
10. Chao, T O., Byron, K. L. Lee, K. Viliereal, M , and Rosner, M. R. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. J. Biol. Chem., 267: 19876-19883, 1992.
11. Davis, R. J. MAPKs. new JNK expands the group. Trends Biochem Sci., 79: 470-473, 1994
12. Dérijard, B., Hibi, M , Wu, I., Barrett, T., Su, B., Deng, T , Kann, M., and Davis, R. J JNK1 a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell, 76: 1025-1037, 1994
13. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes & Dev., 7: 2135-2148, 1993.
14. Whitmarsh, A. J., Shore, P., Sharrocks, A D , and Davis, R. J Integration of MAP kinase signal transduction pathways at the serum response element. Science (Washington DC). 269. 403-407, 1995.
15. Gupta, S Campbell, D., Dérijard, B. and Davis, R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (Washington DC), 267: 389-393, 1995.
16. Corpuz, G P., Grothaus, P. G , Waller, D. F , and Bignami, G. S. An HPLC method for rapid analysis of palytoxin congeners and prodrugs. In: Y. Hokama, P. J. Scheuer, and T. Yasumoto (eds ), Proceedings of the International Symposium on Ciguatera and Marine Natural Products, pp 143-151. Honolulu: Asian Pacific Research Foundation, 1995.
17. Moore, R E., and Scheuer, P. J. Palytoxin: a new marine toxin from a coelenterate. Science (Washington DC). 172: 495-498, 1971
18. Smith, S B., and Johnson, K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (Amst.), 67. 31-40, 1988.
19. Taylor, T. J., Parker, G W., Fajer, A. B., and Mereish, K. A. Non-specific binding of palytoxin to plastic surfaces. Toxicol. Lett.. 57: 291-296, 1991.
20. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Dérijard B., Moore, G., Davis, R., and Karin, M. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes & Dev., 8: 2996-3007, 1994.
21. Wattenberg, E. V., McNeil, P. L., Fujiki, H., and Rosner, M. R. Palytoxin downmodulates the epidermal growth factor receptor through a sodium-dependent pathway. J. Biol. Chem., 264, 213-219, 1989.
22. Sauviat, M. Palytoxin: characterization of mode of action in excitable cells. Methods Neurosci., 8: 332-346, 1992.
23. Yoshizumi, M., Nakanishi, A., Houchi, H., Morita, K., Katoh, I., and Oka, M. Characterization of palytoxin-induced catecholamine secretion from cultured bovine adrenal chromaffin cells. Biochem. Pharmacol., 42. 17-23, 1991.
24. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., and Ben-Neriah, Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77: 727-736, 1994.
25. Haystead, T. A., Sim, A T. R., Carling, D., Honnor, R. C., Tsukitani, Y., Cohen, P., and Hardie, D G. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature (Lond.). 337: 78-81, 1989.
26. Yan, M., Dai, T , Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J R., and Templeton, D. J. Activation of stress-activated protein kinase by MEKK1 phosphoryiation of its activator SEK1. Nature (Lond.), 372: 798-800, 1994.
27. Rozengurt, E. Early signals in the mitogenic response. Science (Washington DC). 234: 161-166, 1986.
28. Sánchez, I., Hughes, R. T., Mayer, B. J , Yee, K., Woodgett, J. R., Avruch, J Kyriakis, J M., and Zon, L. I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (Lond), 372: 794-798, 1994.
29. Monguchi, T., Kawasaki, H., Matsuda, S., Gotoh, Y., and Nishida. E Evidence for multiple activators for stress-activated protein kinases/c-Jun amino-terminal kinases J. Biol. Chem., 270: 12969-12972, 1995.
30. Liu, Y., Gorospe, M., Yang, C., and Holbrook, N. J. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. J Biol. Chem. 270: 8377-8380, 1995
31. Sluss, H K., Barrett, T., Dérijard, B., and Davis, R. J. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol., 14: 8376-8384, 1994.
32. Komori, A., Yatsunami, J., Suganuma, M., Okabe, S , Abe, S., Sakai, A., Sasaki, K., and Fujiki, H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res., 53: 1982-1985, 1993.
33. Komori, A., Suganuma, M., Okabe, S., Zou, X., Tius, M. A., and Fujiki, H Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor a release and of protein isoprenylation. Cancer Res., 53. 3462-3464, 1993.